Europe Nonalcoholic Fatty Liver Disease Market Research Report Forecast 2017-2021

June 2017 | 133 pages | ID: E7E54A789E4EN
S&P Consulting

Abstracts

The Europe Nonalcoholic Fatty Liver Disease Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Nonalcoholic Fatty Liver Disease industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Nonalcoholic Fatty Liver Disease market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Nonalcoholic Fatty Liver Disease Market Analysis by Countries:

Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:

Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International

Europe Nonalcoholic Fatty Liver Disease Market Analysis by Product :

• Type 1
• Type 2
• Type 3

Europe Nonalcoholic Fatty Liver Disease Market Analysis by Application:

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 NONALCOHOLIC FATTY LIVER DISEASE MARKET OVERVIEW

1.1 Product Overview and Scope of Nonalcoholic Fatty Liver Disease
1.2 Classification of Nonalcoholic Fatty Liver Disease
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Nonalcoholic Fatty Liver Disease
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Nonalcoholic Fatty Liver Disease Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Nonalcoholic Fatty Liver Disease (2012-2021)
  1.5.1 Europe Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2021)
  1.5.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON NONALCOHOLIC FATTY LIVER DISEASE INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 NONALCOHOLIC FATTY LIVER DISEASE MANUFACTURING COST ANALYSIS

3.1 Nonalcoholic Fatty Liver Disease Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE NONALCOHOLIC FATTY LIVER DISEASE MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Nonalcoholic Fatty Liver Disease Market Competition by Manufacturers
  5.1.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Nonalcoholic Fatty Liver Disease (Volume and Value) by Type
  5.2.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2012-2017)
5.3 Europe Nonalcoholic Fatty Liver Disease (Volume and Value) by Countries
  5.3.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Countries (2012-2017)
5.4 Europe Nonalcoholic Fatty Liver Disease (Volume) by Application

6 GERMANY NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Nonalcoholic Fatty Liver Disease Sales and Value (2012-2017)
  6.1.1 Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  6.1.2 Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
6.2 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
6.3 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
6.4 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

7 FRANCE NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

7.1 France Nonalcoholic Fatty Liver Disease Sales and Value (2012-2017)
  7.1.1 France Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  7.1.2 France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  7.1.3 France Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
7.2 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
7.3 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
7.4 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

8 UK NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

8.1 UK Nonalcoholic Fatty Liver Disease Sales and Value (2012-2017)
  8.1.1 UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  8.1.2 UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  8.1.3 UK Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
8.2 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
8.3 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
8.4 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

9 RUSSIA NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Nonalcoholic Fatty Liver Disease Sales and Value (2012-2017)
  9.1.1 Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  9.1.2 Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
9.2 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
9.3 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
9.4 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

10 ITALY NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Nonalcoholic Fatty Liver Disease Sales and Value (2012-2017)
  10.1.1 Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  10.1.2 Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
10.2 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
10.3 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
10.4 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

11 SPAIN NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Nonalcoholic Fatty Liver Disease Sales and Value (2012-2017)
  11.1.1 Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  11.1.2 Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
11.2 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
11.3 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
11.4 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

12 BENELUX NONALCOHOLIC FATTY LIVER DISEASE (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Nonalcoholic Fatty Liver Disease Sales and Value (2012-2017)
  12.1.1 Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
12.2 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
12.3 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
12.4 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Application

13 EUROPE NONALCOHOLIC FATTY LIVER DISEASE MANUFACTURERS ANALYSIS

13.1 Conatus Pharmaceuticals
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Daewoong Pharmaceutical
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Galmed International
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Kyorin Pharmaceutical
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Metabolic Solutions Development
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Novartis AG
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Phenex Pharmaceuticals
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Raptor Pharmaceuticals
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 TCM Biotech International
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE NONALCOHOLIC FATTY LIVER DISEASE MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Nonalcoholic Fatty Liver Disease Market Forecast by Type (2017-2021)
15.9 Europe Nonalcoholic Fatty Liver Disease Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nonalcoholic Fatty Liver Disease
Table Classification of Nonalcoholic Fatty Liver Disease
Figure Europe Sales Market Share of Nonalcoholic Fatty Liver Disease by Type in 2015
Table Application of Nonalcoholic Fatty Liver Disease
Figure Europe Sales Market Share of Nonalcoholic Fatty Liver Disease by Application in 2015
Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)
Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)
Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)
Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)
Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)
Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)
Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)
Figure Europe Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2021)
Figure Europe Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2021)
Table Europe Nonalcoholic Fatty Liver Disease Sales of Key Manufacturers (2015 and 2016)
Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Figure 2016 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Table Europe Nonalcoholic Fatty Liver Disease Revenue by Manufacturers (2015 and 2016)
Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table 2016 Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Type (2012-2017)
Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Type (2012-2017)
Figure Europe Nonalcoholic Fatty Liver Disease Sales Growth Rate by Type (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Type (2012-2017)
Figure Europe Nonalcoholic Fatty Liver Disease Revenue Growth Rate by Type (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Countries (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Countries (2012-2017)
Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Countries (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Countries (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Countries (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Application (2012-2017)
Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Application (2012-2017)
Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Application (2012-2017)
Figure Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure Germany Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table Germany Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure France Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure France Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table France Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure UK Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table UK Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure Russia Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table Russia Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure Italy Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table Italy Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure Spain Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table Spain Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2012-2017)
Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2012-2017)
Figure Benelux Nonalcoholic Fatty Liver Disease Sales Price Trend (2012-2017)
Table Benelux Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Table Conatus Pharmaceuticals Basic Information List
Table Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2012-2017)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2012-2017)
Table Galmed International Basic Information List
Table Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Galmed International Nonalcoholic Fatty Liver Disease Sales Market Share (2012-2017)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2012-2017)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG Nonalcoholic Fatty Liver Disease Sales Market Share (2012-2017)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2012-2017)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2012-2017)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2012-2017)
Figure TCM Biotech International Nonalcoholic Fatty Liver Disease Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonalcoholic Fatty Liver Disease
Figure Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease
Figure Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
Table Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
Table Major Buyers of Nonalcoholic Fatty Liver Disease
Table Distributors/Traders List
Figure Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2021)
Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2021)
Figure France Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2021)
Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2021)
Figure UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2021)
Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2021)
Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2021)
Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2021)
Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2021)
Table Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Type (2017-2021)
Table Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Application (2017-2021)